Shubin Qiao

Showing 1-7 of 7 articles

Outcomes of Quantitative Flow Ratio-Based Percutaneous Coronary Intervention in an All-Comers Study

Zhang R, Dou K, Guan C, Zou T, Zhang M, Yuan S, Qiao Z, Xie L, Sun Z, Song L, Qiao S, Stone G, Xu B

July 6, 2021 | 10.4244/EIJ-D-21-00176

Coronary interventions

Five-year clinical outcomes of zotarolimus-eluting stents in coronary total occlusions

Kelbæk H, Yeh R, Engstrøm T, Neumann F, Serruys P, Windecker S, Belardi J, Qiao S, Xu B, Liu M, Silber S

March 19, 2021 | 10.4244/EIJ-D-19-00866

Coronary interventions

Double-layer bare metal stents in the treatment of coronary artery aneurysm: experience and outcomes in nine patients

Qiao S, Xiaowei J, Cui J, Li J, Yuan J, Liu S, Gao L, Zhao J, Chen H, Ma J

September 20, 2019 | 10.4244/EIJ-D-18-01093

STEMI

Comparison between two biodegradable polymer-based sirolimus-eluting stents with differing drug elution and polymer absorption kinetics: two-year clinical outcomes of the PANDA III trial

Wang J, Guan C, Qiao S, Cao X, Qin L, Li Y, Li Z, Li X, Yuan J, Gao R, Xu B

October 12, 2018 | 10.4244/EIJ-D-17-00946

Impact of residual SYNTAX score on clinical outcomes after incomplete revascularisation percutaneous coronary intervention: a large single-centre study

Song Y, Gao Z, Tang X, Jiang P, Xu J, Yao Y, Li J, Zhao X, Qiao S, Yang Y, Gao R, Xu B, Yuan J

November 20, 2017 | 10.4244/EIJ-D-17-00132

Coronary interventions

Comparison of clinical outcomes after multivessel versus single-vessel stenting with the zotarolimus-eluting stent in the RESOLUTE Global Clinical Trial Program

Manoharan G, Belardi J, Du Z, Lee M, Qiao S, Serruys P, Windecker S, Xu B, Yeung A

January 20, 2017 | 10.4244/EIJ-D-16-00079

Coronary interventions

An angiographic tool based on Visual estimation for Risk prEdiction of Side branch OccLusion in coronary bifurcation interVEntion: the V-RESOLVE score system

Dou K, Zhang D, Xu B, Yang Y, Yin D, Qiao S, Wu Y, You S, Wang Y, Yan R, Gao R, Kirtane A

April 8, 2016 | 10.4244/EIJV11I14A311

1

Latest news

STATE OF THE ART

Transcatheter treatment for tricuspid valve disease

This State-of-the-Art - by F. Praz et al - reviews the available transcatheter therapies, main criteria for patient and device selection, remaining uncertainties, and future directions

November 19, 2021

PCR London Valves Edition: state of the art on transcatheter treatment for tricuspid valve disease, a mini focus on TR; coronary access after TAVI and more…

November 19, 2021

EuroIntervention is now on Instagram

November 29, 2021

Long-term impact of OCT-assessed suboptimal stent deployment

Francesco Prati et al.

November 25, 2021

Percutaneous tricuspid valve annuloplasty: additional data and remaining questions

Nicole Karam et al.

November 23, 2021

Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?

Josep Rodés-Cabau et al.

November 23, 2021

Guidelines, consensus & position papers

consult the most recent published guidelines, consensus and position papers

November 29, 2021

Valvular disease